(Q36554773)

14 August 2017

1 reference

title

Diagnosis of renal osteodystrophy (English)

1 reference

14 August 2017

Schwarz C

1

1 reference

PubMed ID

16884394

14 August 2017

Sulzbacher I

series ordinal

2

1 reference

PubMed ID

16884394

14 August 2017

Oberbauer R

series ordinal

3

1 reference

14 August 2017

1 August 2006

1 reference

European Journal of Clinical Investigation

14 August 2017

1 reference

14 August 2017

36 Suppl 2

1 reference

14 August 2017

13-22

1 reference

Bone resorption by osteoclasts

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Serum osteoprotegerin and renal osteodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Studies on action of menaquinone-7 in regulation of bone metabolism and its preventive role of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Soluble cathepsin-L: a marker of bone resorption and bone density?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Cross-linking of collagen. Isolation, structural characterization and glycosylation of pyridinoline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Circulating biochemical markers of bone remodeling in uremic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Osteoprotegerin and bone mineral metabolism in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Maintaining low concentrations of plasma beta 2-microglobulin through continuous slow haemofiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Evidence that three structural genes code for human alkaline phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Increased bone formation in osteocalcin-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Kidney-bone, bone-kidney, and cell-cell communications in renal osteodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Vitamin K status in relation to bone metabolism in patients with renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

A novel mechanism for skeletal resistance in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Influence of PTH assay methodology on differential diagnosis of renal bone disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Vitamin-D deficiency in the osteomalacia of chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Renal phosphate loss in hereditary and acquired disorders of bone mineralization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

FGF-23 in patients with end-stage renal disease on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Diagnosis of renal osteodystrophy: when and how to use biochemical markers and non-invasive methods; when bone biopsy is needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Skeletal status in adolescents with end-stage renal failure: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2006.01666.X

10.1111/J.1365-2362.2006.01666.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16884394